Detalhe da pesquisa
1.
Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer.
Oncologist
; 24(8): 1095-1102, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30975923
2.
A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia.
Am J Hematol
; 92(3): 286-291, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28052413
3.
Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy.
Cancer
; 122(15): 2418-25, 2016 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27176138
4.
Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial.
Lancet Oncol
; 16(9): 1071-1078, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26272768
5.
Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials.
Lancet Oncol
; 16(9): 1079-1089, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26272769
6.
Phase 1/2 study of KRN330, a fully human anti-A33 monoclonal antibody, plus irinotecan as second-line treatment for patients with metastatic colorectal cancer.
Invest New Drugs
; 32(4): 682-90, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24691674
7.
Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial.
Lancet Oncol
; 14(1): 72-80, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23246022
8.
Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma.
Cancer Med
; 11(2): 358-370, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34921527
9.
Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: phase 1 study with a dose-expansion cohort.
Cancer
; 117(22): 5067-73, 2011 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21681734
10.
Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant.
J Clin Oncol
; 21(8): 1452-8, 2003 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12697866
11.
An educational program to increase cervical and breast cancer screening in Hispanic women: a Southwest Oncology Group study.
Cancer Nurs
; 28(1): 47-53, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15681982
12.
PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-cell lung cancer.
J Thorac Oncol
; 10(1): 134-42, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25371077
13.
A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer.
Cancer Chemother Pharmacol
; 66(2): 287-94, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19855966
14.
Phase III multicenter trial of doxorubicin plus cyclophosphamide followed by paclitaxel compared with doxorubicin plus paclitaxel followed by weekly paclitaxel as adjuvant therapy for women with high-risk breast cancer.
J Clin Oncol
; 28(18): 2958-65, 2010 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20479419
15.
Efficacy and toxicity of the novel chemotherapeutic agent KW-2170 in recurrent epithelial ovarian cancer.
Gynecol Oncol
; 102(2): 338-42, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16487997